Since our establishment in 1958, we have embraced our responsibility in healthcare as one of Türkiye’s well-established pharmaceutical manufacturers.
To make healthy living accessible to everyone by delivering innovative and differentiated healthcare solutions with uncompromising quality.
To become the preferred choice by building leading pharmaceutical brands in the areas we operate.
A Journey Built on Trust
Discover DEVA
International Markets
Through our manufacturing approach aligned with international quality standards, we make our healthcare solutions accessible worldwide.
Innovation Powered by Science
With our strong R&D infrastructure and scientific expertise, we develop innovative and value-added healthcare solutions.
Responsible Manufacturing
Through environmentally responsible manufacturing processes and our commitment to sustainability, we create value for a sustainable future.
Experience
67 Years
Manufacturing Facilities
4
Annual Production Capacity
620000000 Units
Employees
3000+
Our Manufacturing Strength
Our manufacturing facilities operate in line with international quality standards, forming the foundation of a reliable and sustainable production infrastructure.
Cerkezkoy, Tekirdag
Çerkezköy-I Manufacturing Facility
Çerkezköy-I Manufacturing Facility
Cerkezkoy, Tekirdag
·
52,000 m²
Located approximately 110 km from Istanbul, the Çerkezköy-I Manufacturing Facility is situated within the Çerkezköy Organized Industrial Zone. The site is built on a 52,000 m² area, with 43,000 m² of enclosed production space.
The facility comprises separate buildings dedicated to the production of liquid and semi-solid forms, solid dosage forms, cephalosporins, penicillins, hormone products, inhalation products, sterile liquid ampoules and vials, as well as softgel capsules.
In 2025, the facility produced 183 million boxes of pharmaceutical products.
Cerkezkoy, Tekirdag
Çerkezköy-II Manufacturing Facility
Çerkezköy-II Manufacturing Facility
Cerkezkoy, Tekirdag
·
67,551 m²
Located approximately 110 km from Istanbul, the Çerkezköy-II Manufacturing Facility is situated within the Çerkezköy Organized Industrial Zone. Built on a 67,551 m² site, the facility includes 50,270 m² of enclosed production space.
The facility houses manufacturing units dedicated to high-potent products, sterile liquid oncology products, animal health products, and active pharmaceutical ingredients (API).
The Biotechnology Building, Central Stability Building, and R&D Center Buildings are also located within the Çerkezköy-II Manufacturing Facility.
In 2025, the facility produced 4.83 million units of finished pharmaceutical products.
Kartepe, Kocaeli
Kartepe Manufacturing Facility
Kartepe Manufacturing Facility
Kartepe, Kocaeli
·
32,000 m²
Located in Kartepe, Kocaeli, on the İzmit–Ankara Highway, the DEVA Holding Kartepe Manufacturing Facility is built on a 32,000 m² site, with 16,500 m² of enclosed production space.
The facility consists of modern buildings dedicated to the production of sterile liquid pharmaceuticals, empty medical ampoules, and cologne products.
Cerkezkoy, Tekirdag
Çerkezköy-IV Logistics Center
Çerkezköy-IV Logistics Center
Cerkezkoy, Tekirdag
·
58,000 m²
The Çerkezköy-IV Logistics Center is one of Türkiye’s largest pharmaceutical logistics hubs, featuring a modern distribution infrastructure. Built on a 58,000 m² site, the center includes 23,000 m² of enclosed warehouse space and a storage capacity of 43,500 pallets, supporting DEVA’s robust supply chain management.
With its advanced logistics infrastructure and high storage capacity, the center enables the safe, fast and efficient handling of products. It ensures seamless distribution operations from manufacturing facilities to markets.
Our Awards
Our work in R&D and innovation has been recognized with numerous prestigious awards by leading industry organizations.
Crystal Mortar Award
Recognized for our achievements in R&D and innovation, we have received awards in multiple categories at the Crystal Mortar Awards, presented during the International Drug Chemistry Congress organized by the Turkish Chemists’ Association.
2025
Crystal Mortar Award – Pharmaceutical R&D Expenditure Category
13th International Drug Chemistry Congress (Turkish Chemical Society)
R&D Expenditure – First Prize
2025
Crystal Mortar Award – Pharmaceutical R&D Personnel with Master’s and PhD Degrees Category
13th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Personnel with Master’s and PhD Degrees – First Prize
2025
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
13th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Projects – Third Prize
2025
Crystal Mortar Award – Scientific Publications in the Pharmaceutical Industry Category
13th International Drug Chemistry Congress (Turkish Chemical Society)
Scientific Publications in the Pharmaceutical Industry – First Prize
2025
Crystal Mortar Award – Special Congress Award
13th International Drug Chemistry Congress (Turkish Chemical Society)
Active Pharmaceutical Ingredient Manufacturers – Special Congress Award
2025
Crystal Mortar Award – Total and Female R&D Personnel Category
13th International Drug Chemistry Congress (Turkish Chemical Society)
Total and Female R&D Personnel – First Prize
2024
Crystal Mortar Award – Pharmaceutical R&D Brand Count Category
12th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Brands – Third Prize
2024
Crystal Mortar Award – Pharmaceutical R&D Expenditure Category
12th International Drug Chemistry Congress (Turkish Chemical Society)
R&D Expenditure – First Prize
2024
Crystal Mortar Award – Pharmaceutical R&D Personnel with Master’s and PhD Degrees Category
12th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Personnel with Master’s and PhD Degrees – First Prize
2024
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
12th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Projects – Second Prize
2024
Crystal Mortar Award – Pharmaceutical R&D Total and Female Personnel Category
12th International Drug Chemistry Congress (Turkish Chemical Society)
Total and Female R&D Personnel – First Prize
2024
Crystal Mortar Award – Special Congress Award
12th International Drug Chemistry Congress (Turkish Chemical Society)
Active Pharmaceutical Ingredient Manufacturers – Special Congress Award
2023
Crystal Mortar Award – Pharmaceutical R&D Brand Count Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Brands – Third Prize
2023
Crystal Mortar Award – Pharmaceutical R&D Expenditure Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
R&D Expenditure – First Prize
2023
Crystal Mortar Award – Pharmaceutical R&D Female Personnel Count Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
Number of Female R&D Personnel – First Prize
2023
Crystal Mortar Award – Pharmaceutical R&D Personnel Count Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Personnel – First Prize
2023
Crystal Mortar Award – Pharmaceutical R&D Personnel with Master’s and PhD Degrees Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Personnel with Master’s and PhD Degrees – First Prize
2023
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
11th International Drug Chemistry Congress (Turkish Chemical Society)
Number of R&D Projects – Second Prize
2023
Crystal Mortar Award – Special Congress Award
11th International Drug Chemistry Congress (Turkish Chemical Society)
Active Pharmaceutical Ingredient Manufacturers – Special Congress Award
2022
Crystal Mortar Award – Pharmaceutical R&D Expenditure Category
10th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest R&D Expenditure – First Prize
2022
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
10th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest Number of R&D Projects – First Prize
2021
Crystal Mortar Award – Pharmaceutical R&D Brand Count Category
9th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest Number of Brands – Third Prize
2021
Crystal Mortar Award – Pharmaceutical R&D Expenditure Category
9th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest R&D Expenditure – First Prize
2021
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
9th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest Number of R&D Projects – First Prize
2020
Crystal Mortar Award – Pharmaceutical R&D Project Count Category
8th International Drug Chemistry Congress (Turkish Chemical Society)
Pharmaceutical Company with the Highest Number of R&D Projects – First Prize
1
/
Golden Mortar Award
Our pharmaceutical R&D achievements have earned us the “Best R&D Company of the Year” award multiple times at the Golden Mortar Awards, organized by Eczacı Dergisi.
2022
The Golden Mortar Award - Pazopanib Hydrochloride
12th Golden Mortar Awards (Eczacı Magazine)
Pazopanib Hydrochloride Project – R&D Award
2017
The Golden Mortar Award - Lenalidomide
Golden Mortar Awards
Lenalidomide Study – “R&D Company of the Year”
2015
The Golden Mortar Award - Active Pharmaceutical Ingredients for Hypertension
Golden Mortar Awards
Active Pharmaceutical Ingredients for Hypertension Study – “R&D Company of the Year”
2013
The Golden Mortar Award - Imatinib (CML)
Golden Mortar Awards
Imatinib (CML) Study – “R&D Company of the Year”
1
/
R&D Top 250
We have ranked first in the pharmaceutical sector multiple times in the R&D Top 250 list, published annually by Turkishtime Magazine.
2024
R&D Top 500 – Pharmaceutical Sector First Place
TURKISHTIME R&D Top 500 List
Pharmaceutical Sector – First Place
2023
R&D Top 250 – Pharmaceutical Sector First Place
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
2022
R&D Top 250 – Pharmaceutical Sector First Place
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
2021
R&D Top 250 - Top Twenty and Pharmaceutical Sector Leader
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
2020
R&D Top 250 Pharmaceutical Sector Leader
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
2019
R&D Top 250 Pharmaceutical Sector Leader
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
2018
R&D Top 250 Pharmaceutical Sector Leader
TURKISHTIME R&D Top 250 List
Pharmaceutical Sector – First Place
1
/
Other Awards
Our achievements in R&D, innovation and operational excellence have been recognized with numerous awards from various institutions and organizations.
2025
Enocta Catalog Virtuoso Award
Enocta Catalogue Virtuoso Awards
Devakademi – “Catalogue Virtuoso” Award
2025
Kariyer.net Respect for People Award
Kariyer.net Respect for People Awards
Human Resources – “Respect for People” Award
2025
The ONE Awards - Most Reputable of the Year
The ONE Awards – Integrated Marketing Awards
“Most Reputable of the Year” Award (Pharmaceutical)
2024
Doktorclub Awards - R&D/Innovation Application of the Year
Doktorclub Awards
“R&D / Innovation Application of the Year” Award
2023
Productivity Project Awards - R&D Category First Prize
Productivity Project Awards (Republic of Türkiye Ministry of Industry and Technology)
R&D Category – First Prize
2022
11th Chemistry R&D Project Market Award
11th Chemical R&D Project Market (İKMİB)
Sugammadex Sodium Project – First Prize in the Pharmaceutical Category
2015
Private Sector Best R&D Center Award
4th Private Sector R&D Centers Summit (Ministry of Science, Industry and Technology)
“Best R&D Center” Award
1
/
Our Sustainable Impact
We embrace an impact approach that equally prioritizes people, society, and nature by combining production that respects planetary boundaries, social benefit, and transparent governance.